The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / New Assay Aids In Evaluating Metabolic Effects of Glucocorticoids

New Assay Aids In Evaluating Metabolic Effects of Glucocorticoids

October 31, 2014 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Physicians often prescribe prednisolone and other glucocorticoids (GCs) despite the fact that these antiinflammatory drugs are known to have a negative effect on glucose metabolism. Thus, there is a need for an effective GC that delivers a better safety profile. Unfortunately, efforts to evaluate the side effect of impaired glucose metabolism are hampered by a limited ability to quantify insulin resistance in animal trials. In particular, researchers have found it difficult to measure GC-induced insulin resistance in mice.

You Might Also Like
  • Metabolic Syndrome Linked to Higher Risk for Immunological Disorders
  • The Evolution of Glucocorticoids
  • Glucocorticoids a Fracture Risk at Any Dose
Also By This Author
  • Diagnosis, Treatment Updates for Lyme Arthritis

Erik J. M. Toonen, PhD, a postdoctoral fellow at the Radboud University Nijmegen Medical Centre in The Netherlands, and colleagues addressed this research gap by publishing an integrative model of drug-induced metabolic dysregulation in the September issue of PLoS ONE.1 They describe an accurate whole-body glucose test that is effective in a chronic collagen-induced arthritis (CIA) mouse model. The all-in-one model is designed to be useful for studying both the efficacy of novel GC compounds in the treatment of arthritis and the effects of novel GC compounds on glucose kinetics.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The team focused their investigation on prednisolone. They first documented prednisolone as an effective treatment for CIA, then compared prednisolone with placebo, as well as to a non-GC anti-inflammatory compound called ORG 37663. Inclusion of ORG 37663 in the study allowed the investigators to distinguish between direct and indirect drug effects on metabolism. Thus, the investigators were able to assess if the reduction of insulin sensitivity seen with prednisolone was specific to GC or was a downstream effect of the suppression of inflammation. The investigators found that treatment of arthritic and non-arthritic mice with prednisolone or ORG 37663 resulted in reduced thymus weight. As expected, arthritic mice had decreased arthritic score and X-ray scored upon treatment with either prednisolone or ORG 37663.

The investigators then compared the glucose metabolism of mice with and without arthritis. They first confirmed that their blood glucose kinetics test did not influence the development of arthritis. Once this was established, they used the assay to reveal that there was no difference in blood glucose concentrations between arthritic and non-arthritic mice before treatment. They did find, however, that the metabolic clearance rate (MCR) glucose parameter was increased in untreated arthritic mice vs. untreated non-arthritic mice. In addition, endogenous glucose production (EGP) in untreated arthritic mice was significantly higher than in the untreated non-arthritic mice. After three weeks of treatment with placebo, arthritic mice had lower plasma C-peptide concentrations than did placebo-treated non-arthritic mice. Placebo-treated arthritic mice were also 2.4 times more insulin sensitive than placebo-treated non-arthritic mice.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: DMARDs & Immunosuppressives, Drug Updates, Research Reviews Tagged With: Arthritis, Glucocorticoids, glucose, metabolism, Test, Treatment

You Might Also Like:
  • Metabolic Syndrome Linked to Higher Risk for Immunological Disorders
  • The Evolution of Glucocorticoids
  • Glucocorticoids a Fracture Risk at Any Dose
  • Metabolic Profiling of SLE

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)